Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist
Journal of Medicinal Chemistry2002Vol. 45(21), pp. 4589–4593
Citations Over TimeTop 10% of 2002 papers
Iyassu K. Sebhat, William J. Martin, Zhixiong Ye, Khaled Barakat, Ralph T. Mosley, David B. Johnston, Raman K. Bakshi, Brenda L. Palucki, David H. Weinberg, Tanya MacNeil, Rubana N. Kalyani, Rui Tang, Ralph A. Stearns, Randy R. Miller, Constantin Tamvakopoulos, Alison M. Strack, Erin McGowan, Doreen E. Cashen, Jennifer E. Drisko, Gary J. Hom, Andrew D. Howard, D. Euan MacIntyre, Lex H.T. Van der Ploeg, Arthur A. Patchett, Ravi P. Nargund
Abstract
Synthetic and natural peptides that act as nonselective melanocortin receptor agonists have been found to be anorexigenic and to stimulate erectile activity. We report the design and development of 1, a potent, selective (1184-fold vs MC3R, 350-fold vs MC5R), small-molecule agonist of the MC4 receptor. Pharmacological testing confirms the food intake lowering effects of MC4R agonism and suggests another role for the receptor in the stimulation of erectile activity.
Related Papers
- → Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model‐fitting approach(1993)48 cited
- → Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor(2021)40 cited
- → Melanocortin Pathways: Suppressed and Stimulated Melanocortin-4 Receptor (MC4R)(2020)26 cited
- → Predicting the Activation of the Androgen Receptor by Mixtures of Ligands Using Generalized Concentration Addition(2020)6 cited
- → Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.(1989)12 cited